首頁 > 市場調查報告書 > 製藥

生技設備生物工藝

亞太地區生物加工市場預測至 2031 年 - 區域分析 - 按產品、營運規模、製程、應用和最終用戶

市場調查報告書

商品編碼

1597071

亞太地區生物加工市場預測至 2031 年 - 區域分析 - 按產品、營運規模、製程、應用和最終用戶

Asia Pacific Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product, Scale of Operation, Process, Application, and End User

出版日期: 2024年10月03日 | 出版商:

The Insight Partners | 英文 168 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023年亞太生物加工市場價值為54.8887億美元，預計2031年將達到168.6877億美元；預計2023年至2031年複合年成長率為15.1%。

個人化醫療需求激增推動亞太生物加工市場

醫療保健產業從一刀切到有針對性的方法的轉變正在擴大對個人化醫療的需求。精準醫學被認為是解決癌症、神經退化性疾病和罕見遺傳疾病等健康問題最有前景的方法之一。個人化藥物生產的創新可能會影響整個產業，而針對小批量生產的一次性技術在蛋白質生物生產中具有潛在的應用，特別是在下游製程。個人化和差異化的醫療方法導致了對更廣泛產品的需求——其中許多產品針對相對較小的患者群體。因此，可能需要一種根本不同的生物產品生產和交付方法。精準醫學利用個體的基因組資訊為特定適應症提供針對性治療。罕見疾病數量的增加增加了對生物製劑和藥物的需求，從而促進了個人化藥物的成長。 2019年，FDA批准了約12種個人化藥物，以解決疾病的根本原因，並進一步將精準醫療與臨床照護結合。此外，政府加強加強個人化醫療研究活動。例如，2020年2月，美國國家人類基因組研究所（NHGRI）宣佈建立新的精準醫學和基因組學計畫。該計劃重點關注基因組學和資訊學工具的創新，以更好地診斷和治療疾病。個人化藥物利用遺傳學和生物資訊學的進步來針對特定的患者群體並治療以前無法治療的疾病。個人化醫療使用生物加工技術來開發客製化療法。從分離特定細胞到開發針對患者的治療方法，生物加工步驟對於生產適合每位患者的治療方法至關重要。因此，預計個人化醫療需求的不斷成長將為預測期內生物加工市場的參與者提供重大的成長機會。

亞太地區生物加工市場概況

亞太地區生物加工市場分為中國、日本、印度、韓國、澳洲和亞太地區其他地區。這些國家的市場成長歸因於慢性病盛行率的上升和有利的報銷政策。此外，市場參與者實施的擴張和產品推出策略預計將有助於該地區生物製程技術市場的成長。 2023年，中國將佔據最大的市場佔有率，而印度預計在預測期內將實現顯著的市場複合年成長率。中國的生物製藥產業正在經歷巨大轉變，從以學名藥為中心的格局演變為蓬勃發展的創新中心。此外，新藥、高階醫療器材和技術的產業化和應用的進步也有助於中國生物加工市場的成長。因此，越來越多的研究中心、不斷增加的政府資助以及市場參與者不斷採取的地理擴張措施推動了亞太地區生物加工市場的成長。

亞太地區生物加工市場收入及 2031 年預測（百萬美元）

亞太地區生物加工市場細分

亞太地區生物加工市場按產品、營運規模、製程、應用、最終用戶和國家進行分類。

根據產品，亞太生物加工市場分為儀器和消耗品及配件。到2023年，儀器儀表領域將佔據更大的市場佔有率。此外，生物反應器細分分為中試規模、全規模和實驗室規模。此外，分段層析系統又分為液相層析、氣相層析等。此外，消耗品和配件細分為試劑、細胞培養基、層析樹脂等。

從營運規模來看，亞太生物加工市場分為商業營運和臨床營運。 2023年，商業營運領域佔據更大的市場佔有率。

依製程分類，亞太生物製程市場分為下游生物製程和上游生物製程。到2023年，下游生物製程領域將佔據更大的市場佔有率。

根據應用，亞太生物加工市場分為單株抗體、疫苗、重組蛋白、細胞和基因治療等。 2023 年，單株抗體細分市場佔最大市場。

就最終用戶而言，亞太生物加工市場分為生物製藥公司、合約製造組織等。 2023 年，生物製藥公司細分市場佔最大市場。

依國家/地區分類，亞太地區生物加工市場分為中國、印度、日本、韓國、澳洲和亞太地區其他地區。 2023年，中國在亞太生物加工市場佔有率中佔據主導地位。

Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Repligen Corp、Entegris Inc、Agilent Technologies Inc 和 Cytiva US LLC。是亞太地區生物加工市場上的一些領先公司。

The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle health concerns such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products-many of them for a relatively small group of patients. Therefore, a fundamentally different approach to the production and delivery of biological products may be required. Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The growing number of orphan diseases has increased the demand for biologics and drugs, which has subsequently boosted the growth of personalized medicines. In 2019, the FDA approved ~12 personalized medications for addressing the root causes of disease and further integrated precision medicine with clinical care. Also, increasing government efforts are strengthening personalized medicine research activities. For instance, in February 2020, the National Human Genome Research Institute (NHGRI) announced to establish a new precision medicine and genomics program. This program focuses on the innovation of genomics and informatics tools for better diagnosis and treatment of disease. Personalized medicines leverage advances in genetics and bioinformatics to target specific patient populations and treat previously untreatable diseases. Personalized medicine uses bioprocessing techniques to develop tailored therapies. From isolating specific cells to developing patient-specific treatments, bioprocessing steps are essential for producing treatments tailored to each patient. Therefore, the rising demand for personalized medicine is predicted to offer significant growth opportunities to the players operating in the bioprocessing market during the forecast period.

Asia Pacific Bioprocessing Market Overview

The Asia Pacific bioprocessing market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising chronic disease prevalence and favorable reimbursement policies. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the bioprocess technology market in the region. China accounted for the largest share of the market in 2023, and India is expected to record a significant CAGR in the market during the forecast period. The biopharmaceutical industry in China is undergoing a tremendous shift, evolving from a generic-focused landscape to a thriving innovation hub. Additionally, progress in industrialization and the application of novel drugs, high-end medical devices, and techniques contribute to the bioprocessing market growth in China. Thus, an increasing number of research centers, rising government funding, and constant initiatives taken by the market players for geographic expansion fuel the bioprocessing market growth in Asia Pacific.

Asia Pacific Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Bioprocessing Market Segmentation

The Asia Pacific bioprocessing market is categorized into product, scale of operation, process, application, end user, and country.

Based on product, the Asia Pacific bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held a larger market share in 2023. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

In terms of scale of operation, the Asia Pacific bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held a larger market share in 2023.

By process, the Asia Pacific bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023.

Based on application, the Asia Pacific bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held the largest market share in 2023.

In terms of end user, the Asia Pacific bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest market share in 2023.

By country, the Asia Pacific bioprocessing market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific bioprocessing market share in 2023.

Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc, and Cytiva US LLC. are some of the leading companies operating in the Asia Pacific bioprocessing market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Bioprocessing Market Landscape

4.1 Ecosystem Analysis
- 4.1.1 List of Vendors in the Value Chain

5. Asia Pacific Bioprocessing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
- 5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
- 5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:

6. Bioprocessing Market - Asia Pacific Analysis

6.1 Asia Pacific Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

7. Asia Pacific Bioprocessing Market Analysis - by Product

7.1 Overview
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
    - 7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
    - 7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
- 7.3.1 Overview
- 7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

8. Asia Pacific Bioprocessing Market Analysis - by Scale of Operation

8.1 Overview
8.2 Commercial Operations
- 8.2.1 Overview
- 8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
- 8.3.1 Overview
- 8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Bioprocessing Market Analysis - by Process

9.1 Overview
9.2 Downstream Bioprocess
- 9.2.1 Overview
- 9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
- 9.3.1 Overview
- 9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Bioprocessing Market Analysis - by Application

10.1 Overview
10.2 Monoclonal Antibodies
- 10.2.1 Overview
- 10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
- 10.3.1 Overview
- 10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
- 10.4.1 Overview
- 10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
- 10.5.1 Overview
- 10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Bioprocessing Market Analysis - by End User

11.1 Overview
11.2 Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
- 11.3.1 Overview
- 11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Bioprocessing Market - Country Analysis

12.1 Asia Pacific
- 12.1.1 Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
  - 12.1.1.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.1.1 Overview
  - 12.1.1.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 China: Bioprocessing Market Breakdown, by Product
    - 12.1.1.2.1.1 China: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.2.2 China: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.2.3 China: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.2.4 China: Bioprocessing Market Breakdown, by Process
    - 12.1.1.2.5 China: Bioprocessing Market Breakdown, by Application
    - 12.1.1.2.6 China: Bioprocessing Market Breakdown, by End User
  - 12.1.1.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Overview
  - 12.1.1.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.4.1 India: Bioprocessing Market Breakdown, by Product
    - 12.1.1.4.1.1 India: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.4.1.2 India: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.4.2 India: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.4.3 India: Bioprocessing Market Breakdown, by Process
    - 12.1.1.4.4 India: Bioprocessing Market Breakdown, by Application
    - 12.1.1.4.5 India: Bioprocessing Market Breakdown, by End User
  - 12.1.1.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.5.1 Overview
  - 12.1.1.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.6.1 Japan: Bioprocessing Market Breakdown, by Product
    - 12.1.1.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.6.2 Japan: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.6.3 Japan: Bioprocessing Market Breakdown, by Process
    - 12.1.1.6.4 Japan: Bioprocessing Market Breakdown, by Application
    - 12.1.1.6.5 Japan: Bioprocessing Market Breakdown, by End User
  - 12.1.1.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.7.1 Overview
  - 12.1.1.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.8.1 South Korea: Bioprocessing Market Breakdown, by Product
    - 12.1.1.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.8.2 South Korea: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.8.3 South Korea: Bioprocessing Market Breakdown, by Process
    - 12.1.1.8.4 South Korea: Bioprocessing Market Breakdown, by Application
    - 12.1.1.8.5 South Korea: Bioprocessing Market Breakdown, by End User
  - 12.1.1.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.9.1 Overview
  - 12.1.1.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.10.1 Australia: Bioprocessing Market Breakdown, by Product
    - 12.1.1.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.10.2 Australia: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.10.3 Australia: Bioprocessing Market Breakdown, by Process
    - 12.1.1.10.4 Australia: Bioprocessing Market Breakdown, by Application
    - 12.1.1.10.5 Australia: Bioprocessing Market Breakdown, by End User
  - 12.1.1.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.11.1 Overview
  - 12.1.1.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product
    - 12.1.1.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process
    - 12.1.1.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application
    - 12.1.1.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sartorius AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Corning Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 3M Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Eppendorf SE
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Repligen Corp
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Entegris Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Agilent Technologies Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 Cytiva US LLC
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market

List Of Figures

Figure 1. Asia Pacific Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Asia Pacific: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market